動物用抗感染症薬市場：動物タイプ、製品タイプ、投与経路、流通チャネル別-2025-2030年世界予測

動物用抗感染症薬市場は、2023年に38億4,000万米ドルと評価され、2024年には42億8,000万米ドルに達すると予測され、CAGR 11.97％で成長し、2030年には84億7,000万米ドルに達すると予測されています。

動物用抗感染症薬市場には、動物の感染症の予防、制御、治療に使用される幅広い医薬品が含まれます。これには抗生物質、抗ウイルス剤、抗真菌剤、抗寄生虫剤などが含まれます。動物用抗感染症薬の必要性は、家畜の健康と生産性を維持し、食の安全を確保し、コンパニオンアニマルに最適なケアを提供する必要性によってもたらされます。これらの製品は、畜産農場、動物病院、水産養殖、コンパニオンアニマルシェルターなど、さまざまな最終用途分野に適用されています。この市場の動向は、動物疾病の発生率の上昇、世界の食糧需要を満たすための家畜生産の増加、特に新興経済圏におけるペット飼育傾向の拡大から大きな影響を受けています。

市場開拓のチャンスは、薬剤開発の進歩、特に広域スペクトル抗感染症薬や耐性菌の可能性を低減した薬剤の開発から生まれます。抗生物質の責任ある使用を促進する規制の変更も、プロバイオティクスやワクチンなどの代替療法に成長の道をもたらします。しかし、厳しい規制要件、高い市場開拓コスト、抗生物質耐性に対する懸念の高まりなど、市場は限界に直面しています。これらの課題には、耐性菌への影響を最小限に抑えた新規治療薬の開発における技術革新が必要です。

研究開発と技術革新は、薬効の強化、抗生物質の誤用を減らすための迅速診断ツールの開発、従来の抗菌薬に代わる天然または合成の代替薬の探索などに焦点を当てることができます。技術革新に最適な分野は、治療成績を向上させる併用薬の処方や新しいデリバリー・メカニズムであろう。持続可能性と環境への影響の最小化にシフトしつつある市場の性質を理解することは、事業戦略を導く上で不可欠です。

業界情勢が複雑化する中、課題を克服し、新たな機会を効果的に活用するためには、業界関係者、学術界、規制機関との連携を重視した、研究開発への多面的なアプローチが必要です。精密医療と総合農業を優先させることで、企業は市場の要求と規制基準により合致し、持続的成長への道を開くことができます。

市場力学：急速に進化する動物用抗感染症薬市場の主要市場インサイトを公開

動物用抗感染症薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 動物ヘルスケアに対する意識の高まり
  • 人獣共通感染症の発生率の上昇
  • ペットの健康に対する関心の高まりに伴うコンパニオンアニマルの採用増加
• 市場抑制要因
  • 獣医療サービスのコスト高
• 市場機会
  • 様々な政府機関や動物協会による好意的な取り組み
  • 動物ヘルスケアにおける研究開発活動の拡大
• 市場の課題
  • 偽造医薬品に関する脅威

ポーターの5つの力：動物用抗感染症薬市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：動物用抗感染症薬市場における外部からの影響の把握

外部マクロ環境要因は、動物用抗感染症薬市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析動物用抗感染症薬市場における競合情勢の把握

動物用抗感染症薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス動物用抗感染症薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、動物用抗感染症薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨動物用抗感染症薬市場における成功への道筋を描く

動物用抗感染症薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 動物のヘルスケアに関する意識の向上
    • 人獣共通感染症の発生率の上昇
    • ペットの健康に対する懸念が高まる中、ペットの飼育が増加
  • 抑制要因
    • 獣医サービスの高額な費用
  • 機会
    • さまざまな政府機関や動物協会による好意的な取り組み
    • 動物ヘルスケアにおける研究開発活動の拡大
  • 課題
    • 偽造医薬品に関連する脅威
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 動物用抗感染症薬市場動物の種類別

• ペット
  • 猫
  • 犬
• 家畜
  • 牛
  • 魚
  • 家禽
  • 羊とヤギ
  • 豚

第7章 動物用抗感染症薬市場：製品タイプ別

• 抗菌
  • セファロスポリン
  • マクロライド
  • ペニシリン
  • テトラサイクリン
• 抗真菌薬
• 抗ウイルス薬

第8章 動物用抗感染症薬市場：投与経路別

• 注射剤
• オーラル

第9章 動物用抗感染症薬市場：流通チャネル別

• eコマース
• 小売薬局
• 獣医クリニック

第10章 南北アメリカの動物用抗感染症薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の動物用抗感染症薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの動物用抗感染症薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Biogenesis Bago SA
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Dechra Pharmaceuticals PLC
• Elanco Animal Health Incorporated
• Evonik Industries AG
• Hester Biosciences Limited
• Huvepharma, Inc.
• Merck & Co., Inc.
• Neogen Corporation
• Nutreco N.V.
• Perrigo Company PLC
• Vetoquinol S.A.
• Virbac S.A.
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. VETERINARY ANTI-INFECTIVES MARKET RESEARCH PROCESS
• FIGURE 2. VETERINARY ANTI-INFECTIVES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. VETERINARY ANTI-INFECTIVES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. VETERINARY ANTI-INFECTIVES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VETERINARY ANTI-INFECTIVES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VETERINARY ANTI-INFECTIVES MARKET DYNAMICS
• TABLE 7. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CAT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DOG, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY FISH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SHEEP & GOATS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY CEPHALOSPORINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY MACROLIDES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PENICILLIN, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY TETRACYCLINES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 29. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY INJECTABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 31. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 32. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 33. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 34. GLOBAL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 35. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 37. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 38. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 39. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 40. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 41. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 42. AMERICAS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 45. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 46. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 47. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 48. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 49. ARGENTINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 51. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 52. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 53. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 55. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 56. BRAZIL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 57. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 59. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 60. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 62. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 63. CANADA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 64. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 66. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 67. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 68. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 69. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 70. MEXICO VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 72. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 73. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 74. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 76. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 77. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 78. UNITED STATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 79. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 80. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 81. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 82. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 84. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 85. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 86. ASIA-PACIFIC VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 87. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 88. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 89. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 90. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 92. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 93. AUSTRALIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 94. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 96. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 97. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 99. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 100. CHINA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 101. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 102. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 103. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 104. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 105. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 106. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 107. INDIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 109. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 110. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 111. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 113. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 114. INDONESIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 116. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 117. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 118. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 119. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 120. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 121. JAPAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 122. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 123. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 124. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 125. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 126. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 127. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 128. MALAYSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 130. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 131. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 132. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 134. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 135. PHILIPPINES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 136. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 137. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 138. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 139. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 141. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 142. SINGAPORE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 143. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 144. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 145. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 146. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 147. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 148. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 149. SOUTH KOREA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 150. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 151. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 152. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 153. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 154. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 155. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 156. TAIWAN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 157. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 158. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 159. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 160. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 161. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 162. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 163. THAILAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 165. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 166. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 167. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 168. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 169. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 170. VIETNAM VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 171. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 172. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 173. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 174. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 175. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 176. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 177. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 178. EUROPE, MIDDLE EAST & AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 179. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 180. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 181. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 182. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 184. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 185. DENMARK VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 186. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 187. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 188. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 189. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 190. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 191. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 192. EGYPT VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 193. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 194. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 195. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 196. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 197. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 198. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 199. FINLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 200. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 201. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 202. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 203. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 204. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 205. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 206. FRANCE VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 207. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 208. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 209. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 210. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 211. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 212. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 213. GERMANY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 214. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 215. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 216. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 217. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 218. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 219. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 220. ISRAEL VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 221. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 222. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 223. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 224. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 226. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 227. ITALY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 228. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 229. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 230. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 231. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 232. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 233. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 234. NETHERLANDS VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 235. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 236. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 237. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 238. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 239. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 240. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 241. NIGERIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 243. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 244. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 245. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 246. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 247. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 248. NORWAY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 249. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 250. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 251. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 252. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 253. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 254. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 255. POLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 256. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 257. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 258. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 259. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 260. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 261. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 262. QATAR VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 263. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 264. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 265. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 266. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 267. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 268. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 269. RUSSIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 270. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 271. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 272. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 273. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 274. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 275. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 276. SAUDI ARABIA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 277. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 278. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 279. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 280. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 281. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 282. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 283. SOUTH AFRICA VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 284. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 285. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 286. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 287. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 288. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 289. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 290. SPAIN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 291. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 292. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 293. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 294. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 295. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 296. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 297. SWEDEN VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 298. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 299. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 300. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 301. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 302. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 303. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 304. SWITZERLAND VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 305. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 306. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 307. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 308. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 309. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 310. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
• TABLE 311. TURKEY VETERINARY ANTI-INFECTIVES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 312. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 313. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY COMPANION ANIMAL, 2018-2030 (USD MILLION)
• TABLE 314. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY LIVESTOCK, 2018-2030 (USD MILLION)
• TABLE 315. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 316. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ANTIBACTERIAL, 2018-2030 (USD MILLION)
• TABLE 317. UNITED ARAB EMIRATES VETERINARY ANTI-INFECTIVES MARKET SIZE, BY ROUTE

The Veterinary Anti-infectives Market was valued at USD 3.84 billion in 2023, expected to reach USD 4.28 billion in 2024, and is projected to grow at a CAGR of 11.97%, to USD 8.47 billion by 2030.

The veterinary anti-infectives market encompasses a broad range of medications used to prevent, control, and treat infections in animals. This includes antibiotics, antivirals, antifungals, and antiparasitic agents. The necessity for veterinary anti-infectives is driven by the need to maintain the health and productivity of livestock, ensure food safety, and provide optimal care for companion animals. These products are applied across various end-use areas such as livestock farms, veterinary clinics, aquaculture, and companion animal shelters. Growth in this market is significantly influenced by the rising incidence of animal diseases, increasing livestock production to meet global food demand, and the expanding pet ownership trend, especially in emerging economies.

Opportunities in the market arise from advancements in drug development, particularly in creating broad-spectrum anti-infectives and those with reduced resistance potential. Regulatory changes promoting the responsible use of antibiotics also present growth avenues for alternative therapies such as probiotics and vaccines. However, the market does face limitations, including stringent regulatory requirements, high development costs, and the growing concern over antibiotic resistance. These challenges necessitate innovations in developing novel therapeutics with minimal resistance impact.

Research and innovation can focus on enhancing drug efficacy, developing rapid diagnostic tools to reduce misuse of antibiotics, and exploring natural or synthetic alternatives to traditional antimicrobials. The best areas for innovation could be in the formulation of combination drugs or new delivery mechanisms that improve treatment outcomes. Understanding the market's nature, which is shifting towards sustainability and minimal environmental impact, is vital for guiding business strategies.

The complex landscape of veterinary anti-infectives requires a multifaceted approach to research and development, with emphasis on collaboration between industry players, academia, and regulatory bodies to overcome challenges and harness emerging opportunities effectively. By prioritizing precision medicine and integrated farming practices, businesses can better align with market demands and regulatory criteria, paving the way for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Veterinary Anti-infectives Market

The Veterinary Anti-infectives Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing awareness regarding animal healthcare
  • Rising incidence of zoonotic diseases
  • Increasing adoption of companion animals with rising concerns to pet wellbeing
• Market Restraints
  • High cost of veterinary services
• Market Opportunities
  • Favorable initiatives by various government agencies and animal associations
  • Growing R&D activities in the animal healthcare
• Market Challenges
  • Threat associated with counterfeit medicines

Porter's Five Forces: A Strategic Tool for Navigating the Veterinary Anti-infectives Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Veterinary Anti-infectives Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Veterinary Anti-infectives Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Veterinary Anti-infectives Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Veterinary Anti-infectives Market

A detailed market share analysis in the Veterinary Anti-infectives Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Veterinary Anti-infectives Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Veterinary Anti-infectives Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Veterinary Anti-infectives Market

A strategic analysis of the Veterinary Anti-infectives Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Veterinary Anti-infectives Market, highlighting leading vendors and their innovative profiles. These include Biogenesis Bago SA, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Hester Biosciences Limited, Huvepharma, Inc., Merck & Co., Inc., Neogen Corporation, Nutreco N.V., Perrigo Company PLC, Vetoquinol S.A., Virbac S.A., and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Veterinary Anti-infectives Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Animal Type, market is studied across Companion Animal and Livestock. The Companion Animal is further studied across Cat and Dog. The Livestock is further studied across Cattle, Fish, Poultry, Sheep & Goats, and Swine.
• Based on Product Type, market is studied across Antibacterial, Antifungals, and Antivirals. The Antibacterial is further studied across Cephalosporins, Macrolides, Penicillin, and Tetracyclines.
• Based on Route of Administration, market is studied across Injectables and Oral.
• Based on Distribution Channel, market is studied across E-Commerce, Retail Pharmacies, and Veterinary Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing awareness regarding animal healthcare
    • 5.1.1.2. Rising incidence of zoonotic diseases
    • 5.1.1.3. Increasing adoption of companion animals with rising concerns to pet wellbeing
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of veterinary services
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable initiatives by various government agencies and animal associations
    • 5.1.3.2. Growing R&D activities in the animal healthcare
  • 5.1.4. Challenges
    • 5.1.4.1. Threat associated with counterfeit medicines
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Veterinary Anti-infectives Market, by Animal Type

• 6.1. Introduction
• 6.2. Companion Animal
  • 6.2.1. Cat
  • 6.2.2. Dog
• 6.3. Livestock
  • 6.3.1. Cattle
  • 6.3.2. Fish
  • 6.3.3. Poultry
  • 6.3.4. Sheep & Goats
  • 6.3.5. Swine

7. Veterinary Anti-infectives Market, by Product Type

• 7.1. Introduction
• 7.2. Antibacterial
  • 7.2.1. Cephalosporins
  • 7.2.2. Macrolides
  • 7.2.3. Penicillin
  • 7.2.4. Tetracyclines
• 7.3. Antifungals
• 7.4. Antivirals

8. Veterinary Anti-infectives Market, by Route of Administration

• 8.1. Introduction
• 8.2. Injectables
• 8.3. Oral

9. Veterinary Anti-infectives Market, by Distribution Channel

• 9.1. Introduction
• 9.2. E-Commerce
• 9.3. Retail Pharmacies
• 9.4. Veterinary Clinics

10. Americas Veterinary Anti-infectives Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Veterinary Anti-infectives Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Veterinary Anti-infectives Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Biogenesis Bago SA
• 2. Boehringer Ingelheim International GmbH
• 3. Ceva Sante Animale
• 4. Dechra Pharmaceuticals PLC
• 5. Elanco Animal Health Incorporated
• 6. Evonik Industries AG
• 7. Hester Biosciences Limited
• 8. Huvepharma, Inc.
• 9. Merck & Co., Inc.
• 10. Neogen Corporation
• 11. Nutreco N.V.
• 12. Perrigo Company PLC
• 13. Vetoquinol S.A.
• 14. Virbac S.A.
• 15. Zoetis Inc.